Savara Inc [SVRA] stock prices are up 12.66% to $5.34 at the moment. An important factor to consider is whether the stock is rising or falling in short-term value. The SVRA shares have gain 15.84% over the last week, with a monthly amount glided 8.54%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 8, April 2024, Savara to Present New Data on Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2024. In a post published today on Yahoo Finance, Savara’s Partner, Trillium Health LLC, to Present Data on the Laboratory Blood Test for Diagnosing aPAP.
From an analyst’s perspective:
Savara Inc [NASDAQ: SVRA] stock has seen the most recent analyst activity on February 15, 2024, when JMP Securities initiated its Mkt Outperform rating and assigned the stock a price target of $8. Previously, Guggenheim started tracking the stock with Buy rating on November 07, 2023, and set its price target to $7. On May 16, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $4 on the stock. Jefferies downgraded its rating to a Hold but stick to its price target of $2 on March 31, 2023. Piper Sandler initiated its recommendation with a Overweight and recommended $7 as its price target on March 16, 2021. Oppenheimer started tracking with a Outperform rating for this stock on March 15, 2021, and assigned it a price target of $4. In a note dated June 13, 2019, H.C. Wainwright reiterated an Buy rating on this stock and revised its target price from $22 to $6.
The stock price of Savara Inc [SVRA] has been fluctuating between $1.67 and $5.70 over the past year. Savara Inc [NASDAQ: SVRA] shares were valued at $5.34 at the most recent close of the market.
Analyzing the SVRA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.44 and Total Capital is -0.36. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.19.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.96 points at the first support level, and at 4.58 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.53, and for the 2nd resistance point, it is at 5.72.
Savara Inc [SVRA] reported earnings per share of -$0.09 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.1/share, meaning a difference of $0.01 and a surprise factor of 10.00%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.1 per share as compared to estimates of -$0.07 per share, a difference of -$0.03 representing a surprise of -42.90%.
Ratios To Look Out For
It’s worth pointing out that Savara Inc [NASDAQ:SVRA]’s Current Ratio is 15.66. On the other hand, the Quick Ratio is 15.66, and the Cash Ratio is 2.51.
Transactions by insiders
Recent insider trading involved Elam Nevan C, Director, that happened on Dec 28 ’23 when 93843.0 shares were sold. CHIEF EXECUTIVE OFFICER, Pauls Matthew completed a deal on Dec 28 ’23 to sell 84000.0 shares. Meanwhile, CHIEF FINANCIAL OFFICER Lowrance David L sold 10000.0 shares on Dec 28 ’23.
